US Opioid Drugs Market Report 2022 to 2030

US Opioid Drugs Market Analysis

$ 3999

US opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 � 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.

ID: IN10USPH345 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Vidhi Upadhyay

Buy Now

US Opioid Drugs Market Analysis Summary

US Opioid Drugs Market is valued at around $11967.1 Mn in 2022 and is projected to reach $13123.8 Mn by 2030, exhibiting a CAGR of 1.16% during the forecast period 2023-2030.

Opioids are regarded as the most successful medications for treating pain. Additionally, the majority of the globe considers their usage in the treatment of chronic pain to be normal practice. Throughout the projection period, the market for opioids is anticipated to expand due to an increase in the burden of medical conditions. When it comes to reducing moderate to severe pain, opioids are very effective. They reduce the experience of pain by attaching to opioid receptors in the brain, spinal cord, and other areas of the body. When someone is in excruciating pain following surgery, an injury, or a medical condition like cancer, opioids can be a lifesaver. They can also be applied in palliative care to lessen suffering towards the end of life. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on the Abuse Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.

Market Dynamics

Market Growth Drivers

The key factors driving the market's rise are an increase in the usage of these medicines and an increase in the older population, who are particularly susceptible to orthopedic pain. Additionally, the number of people who suffer from chronic pain has significantly increased globally. This is expected to contribute to the global opioid market's expansion.

Market Restraints

Stronger regulations and restrictions have been implemented by governments and regulatory authorities regarding the prescription and distribution of opioids. With these measures, opioid overprescribing, inappropriate use, and trafficking into the black market are all to be decreased. Increased regulation and monitoring may make opioids less available and accessible, especially for non-medical uses. Alternatives to opiate pain relief have come into greater emphasis in recent years. Alternative therapies like physical therapy, cognitive-behavioral therapy, acupuncture, and non-opioid painkillers are being researched and promoted by healthcare professionals. This transition away from ad hoc pain management techniques attempts to lessen reliance on opioids and lower the market demand for them.

Competitive Landscape

Key Players

Eva Pharmaceuticals Inc.
Mallinckrodt Pharmaceuticals
Amneal Pharmaceuticals Inc.
Hikma Pharmaceuticals PLC
Purdue Pharmaceuticals L.P

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Opioid Drugs Market Segmentation

By Product Type

Codeine
Fentanyl
Morphine
Meperidine
Methadone
Other

By Receptor Binding

Strong Agonist
Mild to Moderate Agonist

By Applications

Pain Management
Cancer Pain
Neuropathic Pain
Osteoarthritis Pain
Other Pain Managements
Cold and Cough
Diarrhoea
Other Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.